Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 10, Special Issue 1 (2021)

Assessment of stress and immunoglobulin levels of early lactating murrah buffaloes on supplementation of bypass fatty acids and Tinospora cordifolia

Author(s):
Rajneesh, AK Misra, Shwetambri Jamwal, Prince Chauhan and Narender Kumar
Abstract:
The present investigation was undertaken to assess the effect of supplementation of bypass fatty acids and Tinospora cordifolia on stress and immunoglobulin values in early lactating Murrah buffaloes. Twenty freshly calved and healthy buffaloes were selected from institutional herd and divided into four groups having five buffaloes each on the basis of their previous milk yield, body weight and parity. Four groups were assigned as T0 (control), T1 (fatty acid), T2 (Tinospora) and T3 (mix) and were fed with specific amount of supplements for 90 days. In T1 group 150gm of bypass fatty acids, in T2 group 150 gm of Tinospora cordifolia stem powder and in T3 group 150 gm of bypass fatty acids and 150 gm Tinospora cordifolia powder was supplemented over and above the normal ration whereas no supplementation was done in T0 group. Cortisol and IgG levels was analyzed in blood at fortnightly intervals to assess the stress and immunoglobulin levels. Results showed Tinospora supplementation also significantly improved IgG concentrations in T2 and T3 in comparison to T0 and T1. It was concluded that bypass fatty acids and Tinospora cordifolia supplementation positively reduces stress and increases immunoglobulin concentration in early lactating Murrah buffaloes.
Pages: 49-52  |  107 Views  9 Downloads
How to cite this article:
Rajneesh, AK Misra, Shwetambri Jamwal, Prince Chauhan and Narender Kumar. Assessment of stress and immunoglobulin levels of early lactating murrah buffaloes on supplementation of bypass fatty acids and Tinospora cordifolia. The Pharma Innovation Journal. 2021; 10(1S): 49-52.
The Pharma Innovation Journal